Image credit: Clean Technica
Adriana Bello on 30th Aug

FDA approves Novartis’ new gene editing drug Kymriah to treat childhood leukemia

The U.S. Food and Drug Administration approved Wednesday a breakthrough cancer drug to treat childhood leukemia. The “living...

Read More
FDA advisory committee recommends approval of T-cell 'living drug' to treat leukemia. Image credit: Blood Journal
Adriana Bello on 13th Jul

FDA advisory committee recommends approval of T-cell ‘living drug’ to treat leukemia

A new kind of cancer treatment received U.S. regulatory approval on Wednesday. The treatment uses genetically edited cells...

Read More
Daniel Contreras on 29th Jun

Novartis Drug Secukinumab Exhibited Consistent Efficacy in Psoriatic Arthritis Patients

Latest trials conducted on Novartis AG drug Cosentyx or secukinumab showed it to be superior to placebo and also exhibited...

Read More